Bristol-Myers Squibb logo

Bristol-Myers Squibb

North America, New York, United States, New York

Description

Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.

Investor Profile

Bristol-Myers Squibb has made 100 investments, with 16 in the past 12 months and 32% as lead.

Stage Focus

  • Series B (31%)
  • Series A (21%)
  • Grant (16%)
  • Series C (14%)
  • Post Ipo Equity (6%)
  • Series Unknown (4%)
  • Series D (3%)
  • Corporate Round (3%)
  • Series G (1%)
  • Debt Financing (1%)

Country Focus

  • United States (73%)
  • United Kingdom (10%)
  • Germany (3%)
  • France (3%)
  • Denmark (2%)
  • India (2%)
  • Brazil (2%)
  • Israel (2%)
  • Spain (1%)
  • Switzerland (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Health Diagnostics
  • Oncology
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bristol-Myers Squibb frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 7
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 6
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 7
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 12
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 5
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 9
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 13
CH
North America, New York, United States, New York
Co-Investments: 7
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 9
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 8

Which angels does Bristol-Myers Squibb often collaborate with?

Shared Deals: 1
RA
Europe, Rostov, Russian Federation, Novaya
Shared Deals: 1

What are some of recent deals done by Bristol-Myers Squibb?

Be Biopharma

Cambridge, Massachusetts, United States

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

BiopharmaBiotechnologyPharmaceutical
Series CJan 15, 2025
Amount Raised: $92,000,000
Light Horse Therapeutics

San Diego, California, United States

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Biotechnology
Series AJan 9, 2025
Amount Raised: $62,000,000
Bridgeway Behavioral Health Services

Elizabeth, Colorado, United States

Bridgeway is an NJ State licensed nonprofit organization providing services to youth and adults experiencing mental health conditions.

Health CareMental Health
GrantDec 18, 2024
Nuvig Therapeutics

Redwood City, California, United States

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

BiotechnologyHealth CareTherapeutics
Series BDec 5, 2024
Amount Raised: $161,000,000
Be Biopharma

Cambridge, Massachusetts, United States

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

BiopharmaBiotechnologyPharmaceutical
Series UnknownOct 22, 2024
Amount Raised: $82,000,000
Prime Medicine

Cambridge, Massachusetts, United States

Prime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.

BiotechnologyGeneticsLife ScienceMedical
Corporate RoundSep 30, 2024
Amount Raised: $55,000,000
Aktis Oncology

Boston, Massachusetts, United States

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

BiotechnologyHealth CareLife ScienceOncology
Series BSep 30, 2024
Amount Raised: $175,000,000
ArsenalBio

South San Francisco, California, United States

ArsenalBio is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.

BiotechnologyCloud ComputingLife ScienceMedical
Series CSep 4, 2024
Amount Raised: $325,000,000
Abata Therapeutics

Cambridge, Massachusetts, United States

Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.

BiotechnologyMedicalTherapeutics
Corporate RoundAug 15, 2024
Roswell Park Cancer Institute

Buffalo, New York, United States

Roswell Park Cancer Institute provides a multidisciplinary approach for scientists and clinicians to research on Oncology.

Clinical TrialsHealth CareHospitalOncology
GrantAug 12, 2024
Amount Raised: $689,000